<p>Each subject is depicted in a different color with time points connected by a line. The y-axis depicts NR and NAD+ concentrations in μM, and the x-axis depicts values on Day 1 (baseline) and then time post-dose in hours on Day 9. The baseline time point was collected pre-dose on Day 1 of the trial.</p
<p>(A), (B), and (C) are the concentration profiles of at times weeks (short time), weeks (time a...
<p>Mean plasma concentration-time curves of vinorelbine (A) on Day 1 after initial oral dose with CS...
<p>(A) Dose-time curves; (B) Doses in dots, every dot represents a dose at a time point; (C) C/D rat...
<p>Each subject is depicted in a different color and the time points are connected by a line. The <i...
<p>A concentration versus time plot of NADH and NAD<sup><b>+</b></sup> depicted together. Green line...
<p>Each subject is plotted as a different color. The blue line shows a linear regression of the chan...
<p>Red points represent concentrations measured in patients who died during the trial, green points ...
Graph descriptions of contrast concentration-time curves (CCTCs) (a) and comparisons between the ori...
<p>Samples were collected sequentially, when possible, at 5 and 30 min; 1, 1.5, 2, 3, 5, 7, 9, 12, 2...
Data are expressed as % of maximal response to 30 nM substance P. Triangles are [Lys5,MeLeu9,Nle10]-...
<p>The time-course of the average change in oxy-Hb, deoxy-Hb, and total-Hb concentrations in the tem...
<p>A. Representative images from a 5 hour PARP inhibitor pharmacokinetics assay. Far-Left Panel: dru...
<p>The blue lines represent the time evolution of the normalized drug concentration at different cro...
<p>5-HT<sub>1A</sub> RO was determined at assigned time points after oral administration of E2110 at...
<p>Mean plasma concentration-time curves of gemcitabine (A) and dFdU (B) (mean ± standard deviation)...
<p>(A), (B), and (C) are the concentration profiles of at times weeks (short time), weeks (time a...
<p>Mean plasma concentration-time curves of vinorelbine (A) on Day 1 after initial oral dose with CS...
<p>(A) Dose-time curves; (B) Doses in dots, every dot represents a dose at a time point; (C) C/D rat...
<p>Each subject is depicted in a different color and the time points are connected by a line. The <i...
<p>A concentration versus time plot of NADH and NAD<sup><b>+</b></sup> depicted together. Green line...
<p>Each subject is plotted as a different color. The blue line shows a linear regression of the chan...
<p>Red points represent concentrations measured in patients who died during the trial, green points ...
Graph descriptions of contrast concentration-time curves (CCTCs) (a) and comparisons between the ori...
<p>Samples were collected sequentially, when possible, at 5 and 30 min; 1, 1.5, 2, 3, 5, 7, 9, 12, 2...
Data are expressed as % of maximal response to 30 nM substance P. Triangles are [Lys5,MeLeu9,Nle10]-...
<p>The time-course of the average change in oxy-Hb, deoxy-Hb, and total-Hb concentrations in the tem...
<p>A. Representative images from a 5 hour PARP inhibitor pharmacokinetics assay. Far-Left Panel: dru...
<p>The blue lines represent the time evolution of the normalized drug concentration at different cro...
<p>5-HT<sub>1A</sub> RO was determined at assigned time points after oral administration of E2110 at...
<p>Mean plasma concentration-time curves of gemcitabine (A) and dFdU (B) (mean ± standard deviation)...
<p>(A), (B), and (C) are the concentration profiles of at times weeks (short time), weeks (time a...
<p>Mean plasma concentration-time curves of vinorelbine (A) on Day 1 after initial oral dose with CS...
<p>(A) Dose-time curves; (B) Doses in dots, every dot represents a dose at a time point; (C) C/D rat...